125 related articles for article (PubMed ID: 8750157)
1. First-line systemic therapy for metastatic breast cancer and management of pleural effusion.
Perrone F; Carlomagno C; De Placido S; Lauria R; Morabito A; Bianco AR
Ann Oncol; 1995 Dec; 6(10):1033-43. PubMed ID: 8750157
[No Abstract] [Full Text] [Related]
2. [Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastasizing breast cancers. Intermediate report of a multicenter phase III study].
Wander HE; Kleeberg UR; Gärtner E; Hartlapp J; Scherpe A; Bönisch E; Nagel GA
Onkologie; 1987 Apr; 10(2):104-6. PubMed ID: 2954006
[No Abstract] [Full Text] [Related]
3. Weekly low-dose doxorubicin with or without high-dose medroxyprogesterone acetate as secondary treatment in metastatic breast cancer--a randomized trial.
Elomaa I; Blomqvist C; Rissanen P; Mäntylä M
Acta Oncol; 1988; 27(3):297-9. PubMed ID: 2970862
[No Abstract] [Full Text] [Related]
4. Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer.
Pannuti F; Martoni A; Piana E; Tomasi L; Grieco A; Farris A; Saccani F; Baroni M
Chemioterapia; 1984 Aug; 3(4):211-5. PubMed ID: 6241846
[TBL] [Abstract][Full Text] [Related]
5. Positive response to oral chemoendocrine combination therapy using 5"-deoxy-5-fluorouridine for locally advanced breast cancer with carcinomatous pleurisy: report of a case.
Suzuki O; Sekishita Y; Shiono T; Kondo S; Kato H
Surg Today; 2003; 33(12):913-6. PubMed ID: 14669082
[TBL] [Abstract][Full Text] [Related]
6. Progestational agents in advanced breast cancer: an overview.
Haller DG; Glick JH
Semin Oncol; 1986 Dec; 13(4 Suppl 4):2-8. PubMed ID: 3026051
[TBL] [Abstract][Full Text] [Related]
7. Progestin as an alternative treatment option for multi-treated recurrent triple-negative breast cancer.
Xiangying M; Shikai W; Zefei J; Bing S; Yan M; Xin Z; Lijuan D; Yue W; Tao W; Shaohua Z; Santai S
Swiss Med Wkly; 2013; 143():w13765. PubMed ID: 23740185
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
Fossati R; Confalonieri C; Torri V; Ghislandi E; Penna A; Pistotti V; Tinazzi A; Liberati A
J Clin Oncol; 1998 Oct; 16(10):3439-60. PubMed ID: 9779724
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
Gill PG; Gebski V; Snyder R; Burns I; Levi J; Byrne M; Coates A
Ann Oncol; 1993 Nov; 4(9):741-4. PubMed ID: 8280654
[TBL] [Abstract][Full Text] [Related]
10. [Comparative evaluation of the effectiveness of induction chemotherapy using the Cooper, FAC and FAC + MPA protocols in patients with locally advanced breast cancer].
Pawlicki M; Brandys A; Zuchowska B
Nowotwory; 1986; 36(2):124-9. PubMed ID: 2947046
[No Abstract] [Full Text] [Related]
11. Combination chemotherapy in patients with malignant pleural effusions from non-small cell lung cancer : cisplatin, ifosfamide, and irinotecan with recombinant human granulocyte colony-stimulating factor support.
Fujita A; Takabatake H; Tagaki S; Sekine K
Chest; 2001 Feb; 119(2):340-3. PubMed ID: 11171707
[TBL] [Abstract][Full Text] [Related]
12. [A case of recurrent breast cancer with carcinomatous pleurisy successfully treated with combined chemoendocrine-therapy of CTF (CPA, THP and 5-FU) and anastrozole following instillation therapy 12 years after radical mastectomy].
Mori K; Chiba N; Yamamoto Y; Yonekawa H
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2565-8. PubMed ID: 12506484
[TBL] [Abstract][Full Text] [Related]
13. Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: relationship of response to previous treatment.
Blackledge GR; Latief T; Mould JJ; Spooner D; Morrison M
Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1091-4. PubMed ID: 2946584
[TBL] [Abstract][Full Text] [Related]
14. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
Giralt E; Jouve M; Palangie T; Bretaudeau B; Asselain B; Magdelenat H; Merle S; Zajdela A; Pouillart P
Bull Cancer; 1984; 71(1):22-9. PubMed ID: 6324934
[TBL] [Abstract][Full Text] [Related]
15. Metastatic breast cancer: preliminary results with oral hormonal therapy.
Allegra JC; Bertino J; Bonomi P; Byrne P; Carpenter J; Catalano R; Creech R; Dana B; Durivage H; Einhorn L
Semin Oncol; 1985 Dec; 12(4 Suppl 6):61-4. PubMed ID: 3909420
[TBL] [Abstract][Full Text] [Related]
16. [A case of pleural and mediastinal lymph node metastases from breast cancer effectively treated with fadrozole hydrochloride in combination with cyclophosphamide].
Kokufu I; Kim YH; Peng YF; Fukuda K; Yamamoto M; Yano T; Yamada K; Kitano H
Gan To Kagaku Ryoho; 1999 Feb; 26(3):377-9. PubMed ID: 10065105
[TBL] [Abstract][Full Text] [Related]
17. Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide.
Brufman G; Isacson R; Haim N; Gez E; Sulkes A
Oncology; 1994; 51(3):258-61. PubMed ID: 8196908
[TBL] [Abstract][Full Text] [Related]
18. High-dose progestin therapy for metastatic breast cancer.
Muss HB; Cruz JM
Ann Oncol; 1992 Aug; 3 Suppl 3():15-20. PubMed ID: 1390312
[TBL] [Abstract][Full Text] [Related]
19. [Is intrapleural mitoxantrone treatment of pleural effusion effective in pleural metastasis from breast cancer?].
Tejler G
Lakartidningen; 1992 Nov; 89(45):3814. PubMed ID: 1281250
[No Abstract] [Full Text] [Related]
20. High-dose megestrol acetate as third-line endocrine therapy for metastatic breast cancer.
Cruz JM; Muss HB; Russell G
Oncology; 1992; 49 Suppl 2():8-11. PubMed ID: 1461630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
